Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial | NobleBlocks
Public
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
N
Shared by NobleBlocks on Jan 1, 2023 • 12:00 AM UTC